SCHEMBL7042702

SCHEMBL7042702

CCCc1cc(O)c(C(=O)c2ccccc2)cc1O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.55
LMNA P02545 4/20 0.55
HPGD P15428 4/20 0.55
KDM4E B2RXH2 2/20 0.55
CYP3A4 P08684 2/20 0.55
RECQL P46063 1/20 0.55
HSD17B10 Q99714 1/20 0.55
KMT2A Q03164 3/20 0.50
MEN1 O00255 2/20 0.50
GAA P10253 2/20 0.50
USP2 O75604 1/20 0.50
KEAP1 Q14145 1/20 0.50
NFE2L2 Q16236 1/20 0.50
ALDH1A1 P00352 3/20 0.48
CYP1A2 P05177 2/20 0.48
CYP2D6 P10635 2/20 0.48
CYP2C19 P33261 2/20 0.48
MAPK1 P28482 2/20 0.48
PGR P06401 1/20 0.48
SLC6A2 P23975 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17320210 0.84 LMNA (0.62) MAPTLMNAHPGDKDM4ECYP3A4
SCHEMBL27677112 0.82 MAPT (0.50) MAPTLMNAHPGDKDM4ECYP3A4
SCHEMBL9417837 0.82 LMNA (0.55) MAPTLMNAHPGDKDM4ECYP3A4
SCHEMBL7046942 0.81 KMT2A (0.70) MAPTLMNAHPGDKDM4ECYP3A4
SCHEMBL11102516 0.80 HPGD (0.53) MAPTLMNAHPGDKDM4ECYP3A4
SCHEMBL6933360 0.79 PPARG (0.52) HPGDKMT2AMEN1ALDH1A1PPARG
SCHEMBL7252078 0.78 AKR1C3 (0.52) MAPTHPGDKMT2AGAAALDH1A1
SCHEMBL21486417 0.78 KAT8 (0.54) MAPTLMNAHPGDKDM4ECYP3A4
SCHEMBL30070842 0.78 KAT8 (0.54) MAPTLMNAHPGDKDM4ECYP3A4
SCHEMBL28328950 0.78 KMT2A (0.58) MAPTLMNAHPGDKDM4ECYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0882029-B1 HETEROCYCLIC DERIVATIVES AS ANTIDIABETIC AND ANTIOBESITY AGENTS MERCK & CO INC (US) 2003-04-02 EP disclosed
US-6090836-A DIETETICS; ADJUSTMENT OF TRIGLYCERIDE CONCENTRATION MERCK & CO., INC. (US) 2000-07-18 US disclosed
EP-0882029-A1 HETEROCYCLIC DERIVATIVES AS ANTIDIABETIC AND ANTIOBESITY AGENTS Merck & Co., Inc. (US) 1998-12-09 EP disclosed
WO-1997028137-A1 HETEROCYCLIC DERIVATIVES AS ANTIDIABETIC AND ANTIOBESITY AGENTS MERCK & CO., INC. (US) 1997-08-07 WO disclosed